Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-029316
Filing Date
2022-08-19
Accepted
2022-08-19 17:38:20
Documents
1
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4005
  Complete submission text file 0000899243-22-029316.txt   5410
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Therapeutics Inc. (Issuer) CIK: 0001724979 (see all company filings)

EIN.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRINCIPIA BIOPHARMA INC. 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address
Wolff Stefani (Reporting) CIK: 0001751790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40356 | Film No.: 221181729